Found 76 matching trials
Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM PHASE1 The study is an open-label pilot study in newly diagnosed glioblastoma pati...
Show More Location
University of California San Francisco
Learn More & Join Trial
Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE) PHASE1 The study is a prospective, single arm, non-randomized, open label pilot tr...
Show More Location
Multiple Locations
Learn More & Join Trial
Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM NA To test the effectiveness and safety of Optune® given concomitantly with ra...
Show More Location
Grandview Cancer Center
Learn More & Join Trial
TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study N/A This non-interventional study aims to investigate change over time in cogni...
Show More Location
Universitätsklinikum Aachen
Learn More & Join Trial
Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation NA The purpose of the study is to assess timing of TTFields use as well as saf...
Show More Location
University Hospital of Heidelberg, Radiation Oncology
Learn More & Join Trial
Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR) PHASE2 The study is a prospective, single arm, non-randomized, open label phase II...
Show More Location
Antwerp University Hospital, Thoracic Oncology
Learn More & Join Trial
Lenvatinib, Pembrolizumab, and Tumor Treating Fields (TTFields) for Second-line Treatment of Glioblastoma PHASE1 This will be a prospective, open label, single center, phase I lead-in stud...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR) PHASE3 The study is a prospective, randomized controlled phase III trial aimed to ...
Show More Location
Central Alabama Research
Learn More & Join Trial
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma PHASE2 This study consists of 2 portions. The phase 2 portion is an open-label, si...
Show More Status
Active Not Recruiting
Location
Chan Soon-Shiong Institute for Medicine (CSSIFM)
Learn More & Join Trial
Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Best Standard of Care for the Treatment of Hospitalized COVID-19 Patients and Continued Treatment Following Discharge NA The study is a prospective, pilot study aimed to test the safety of Tumor T...
Show More Location
Hadassah Medical Center
Learn More & Join Trial